Retinopathy of prematurity: Prevalence and treatment over a 20 year period at Pennsylvania Hospital

Johnson, Shaffer DB, Boggs TR. Vitamin E deficiency and retrolental fibroplasia. Am J Clin Nutr 1974; 27: 1158–73. Schaffer DB, Johnson L, Quinn G, Boggs TR. A classification of retrolental fibroplasia to evaluate vitamin E therapy. Ophthalmology 1979; 86: 1749–60. Quinn GE, Schaffer DB, Johnson L. A revised classification of retinopathy of prematurity. Am J Ophthalmol 1982; 94: 744–9. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Pediatrics 1984; 74: 127–33. International Committee for the Classification of the Late Stages of Retinopathy of Prematurity II. An international classification of retinal detachment. Arch Ophthalmol 1987; 105: 906–12. Hashim SA. Rapid determination of tocopherol in macro and micro quantities of plasma. Am J Clin Nutr 1966; 19: 136–45. Johnson L, Schaffer D, Quinn, G, et al. Vitamin E supplementation and the retinopathy of prematurity. Ann NY Acad Sci 1982; 393: 473–95. Johnson L, Quinn GE, Abbasi S, et al. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: A controlled clinical trial. J Pediatr 1989; 114: 827–838. Gordon HH, Nitowsky HM, Cornblath M. Studies of tocopherol deficiency in infants and children. I. Hemolysis erythrocytes in hydrogen peroxide. AMA J Dis Child 1955; 90: 669–81. Melhorn DK, Gross S. Vitamin E-dependent anemia in the premature infant. II. Relationship betwen gestational age and absorption of vitamin E. J Pediatr 1971; 79: 581–88. Melhorn D, Gross S. Vitamin E-dependent anemia in the premature infant. I. Effects of large doses of medicinal iron. J Pediatr 1971; 79: 569. Williams M, Shott R, O'Neal P, Oski F. Role of dietary iron and fat on vitamin E deficiency anemia of infancy. N Engl J Med 1975; 292: 887. Hittner HM, Godio LB, Rudolph AJ, et al. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med 1981; 305: 1365–71. Finer NN, Schindler RF, Grant G, et al. Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia: a controlled trial. Lancet 1982; 1: 1087–91. Abbasi S, Johnson L, Bowen FW. The need for a parenteral preparation of vitamin E in low birth weight (BW) infants. Pediatr Res 1983; 17: 149A. Johnson L, Bowen FW, Abbasi S, et al. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1500 grams or less. Pediatrics 1985; 75: 619–38. McCord JM, Fridovich I. The biology and pathology of oxygen radicals. Ann Intern Med 1978; 89: 122–7. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47: 412–26. Kretzer FL, Mehta RS, Johnson AT, et al. Vitamin E protects against retinopathy of prematurity through action on spindle cells. Nature 1984; 309: 793–795. Kretzer FL, Hittner HM. Initiating events in the development of retinopathy of prematurity. In: Silverman WA, Flynn JT, eds. Retinopathy of Prematurity. Boston: Blackwell, 1985; 121–52. Kretzer FL, Hittner HM. Spindle cells and retinopathy of prematurity: interpretation and predictions. In: Flynn JT, Phelps DL, eds. Retinopathy of prematurity: problem and challenge. March of Dimes, Birth Defects Foundation, Original Article Series. New York: Alan R. Liss, Inc., 1988; 24: 147–68. Palmer EA, Phelps D. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Commentary. Pediatrics 1986; 77: 428–429. Keith CG. Visual outcome and effect of treatment in stage III developing retrolental fibroplasia. Br J Ophthalmol 1982; 66: 446–9. Zak TA. Discussion: Natural history of active retinopathy of prematurity. Ophthalmology 1984; 91: 1502–3. Reese AB, King MJ, Owens WC. A classification of retrolental fibroplasia. Am J Ophthalmol 1953; 36: 1333. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group. Multicenter Trial of Cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988; 106: 471–9. Dormandy TL. Free-radical oxidation and antioxidants. Lancet 1978; 1: 647–50. Packer JE, Slater TF, Willson RL. Science 1979; 18: 738–739. Niki E, Saito T, Kawakami A, Kamiya Y: Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C. J Biol Chem 259: 4177–4182, 1984. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159–63. Nielsen JC, Naash MI, Anderson RE. The regional distribution of vitamins E and C in mature and premature human retinas. Invest Ophthalmol Vis Sci 1988; 2: 22–6. Johnson AT, Kretzer FL, Hittner HM, Glazebrook PA, Bridges CDB, Lam DMK. Development of the subretinal space in the preterm human eye: ultrastructural and immunocytochemical studies. J Comp Neurol 1985; 233: 497–505. Johnson AT, Kretzer FL. Interstitial retinol binding protein in the developing human retina: A proposed explanation for vitamin E suppression of retinopathy of prematurity. The Interphotoreceptor Matrix in Health and Disease. Alan R. Liss, Inc. 1985; 251–277. Liou GI, Bridges CDB, Alvarez RA, Fong SL. Binding specificity of interstitial retinolbinding protein: possible physiological consequences of competition between vitamins A and E [Abstract], Ophthalmol Vis Sci 1983; 24 (suppl): 42.